Literature DB >> 11789732

A "percent correction" formula for evaluation of mixing studies.

Sheng-Hsiung Chang1, Veronica Tillema, Doris Scherr.   

Abstract

The study examined a "percent correction" formula for evaluating mixing study results comparing a 1:1 mix with a new 4:1 mix of patient plasma with citrated normal plasma for a prolonged activated partial thromboplastin time (aPTT) and/or prothrombin time (PT). The study also examined 3 suggested definitions of correction for evaluating mixing study results for comparison. Applicability of percent correction for evaluating the aPTT 4:1 mix testing with and without incubation also was studied. Our results showed that percent correction of the aPTT or PT 4:1 mix had an overall good sensitivity and specificity for detecting anticoagulant and factor deficiency and was better than that of the aPTT or PT 1:1 mix. The 3 suggested definitions of correction all had a poor sensitivity for detecting anticoagulant. The percent correction of the aPTT 4:1 mix testing after incubation had better sensitivity and specificity that that of testing immediately. Nevertheless, these procedures were complementary to each other. The percent correction using the aPTT or PT 4:1 mix seemed to offer a simple, objective, and effective criterion for evaluating mixing study results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11789732     DOI: 10.1309/RREK-8L6M-D2KC-HWLH

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  A Confounding Case of Inherited Factor V Deficiency Complicated by Inhibitors at First Presentation.

Authors:  Hema Subramanian; Rakhee Kar; Deepak Charles; Hitha Babu; Pagadalu Ambika; Tarun Kumar Dutta
Journal:  Transfus Med Hemother       Date:  2016-12-13       Impact factor: 3.747

2.  Crosslinking decreases the hemocompatibility of decellularized, porcine small intestinal submucosa.

Authors:  Jeremy J Glynn; Elizabeth G Polsin; Monica T Hinds
Journal:  Acta Biomater       Date:  2014-11-25       Impact factor: 8.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.